Research and Markets: "Competitor Analysis: Anti-Infective Peptides" Provides A Competitor Evaluation In The Field Of R&D Projects

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6558e4/competitor_analysi) has announced the addition of the "Competitor Analysis: Anti-Infective Peptides" report to their offering.

The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of January 2009. Stages of the anti-infective peptide R&D projects range from early research to market.

Anti-Viral Peptides: Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).

Anti-Bacterial Peptides: Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more.

Anti-Fungal Peptides: Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more

Key Topics Covered:

The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and additional comments with a hyperlink leading to the source of information.
• Index
• Anti-Bacterial Peptides
• Anti-Viral Peptides
• Anti-Fungal Peptides
• Corporate PTH Receptor Agonist R&D Pipelines
• Alfacell
• Ambrilia
• Astellas Pharma
• FusoGen Pharmaceutical
• Merck & Co.
• Migenix
• Novacta
• OctoPlus
• ONI Biopharma
• OyaGen
• Pacgen
• PepTx
• Pfizer
• Roche
• SciClone Pharmaceuticals
• University of Western Ontario
• University of Wisconsin
• Viral Genetics
• Xigen
• XOMA

For more information visit http://www.researchandmarkets.com/research/6558e4/competitor_analysi.